CD4 and AIDS: Baseline CD4 count was also highly prognostic for adjusted cumulative mortality, which is illustrated for a typical patient group (MSM in the FHDH cohort, aged 30–39 years, who started ART between 1998 and 1999 without a diagnosis of AIDS, and with high viral load [HIV-1 RNA > 100 000 copies/μL]) in Figure 2.